speb/financial-data huggingface dataset:
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 199600000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 79900000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 79900000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 79900000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 79900000.00
ASCN.SW income_statement (annual, 2025-12-31) — Total Expenses: 271800000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 119700000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 119700000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 52600000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 52600000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 30900000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 30900000.00
ASCN.SW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 20300000.00
ASCN.SW income_statement (annual, 2025-12-31) — Total Other Finance Cost: 400000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 8400000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 8400000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 1838741.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1838741.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Treasury Stock: 7500000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 7500000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Work In Process: 14300000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Work In Process: 14300000.00
ASCN.SW balance_sheet (annual, 2025-12-31) — Working Capital: 58200000.00
ASCN.SW balance_sheet (quarterly, 2025-12-31) — Working Capital: 58200000.00
ASCU.TO income_statement (annual, 2021-12-31) — Basic Average Shares: 46985594.00
ASCU.TO income_statement (annual, 2021-12-31) — Basic EPS: -0.29
ASCU.TO balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 149000.00
ASCU.TO cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -22000.00
ASCU.TO cash_flow (annual, 2021-12-31) — Cash Dividends Paid: 0.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Current Debt: 6729000.00
ASCU.TO income_statement (annual, 2021-12-31) — Diluted Average Shares: 46985594.00
ASCU.TO income_statement (annual, 2021-12-31) — Diluted EPS: -0.29
ASCU.TO balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: 5369000.00
ASCU.TO cash_flow (annual, 2021-12-31) — Interest Paid Cff: -1068000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 0.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Investments And Advances: 0.00
ASCU.TO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 6000000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Land And Improvements: 1826000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 115000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 115000.00
ASCU.TO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 6000000.00
ASCU.TO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 1746000.00
ASCU.TO cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -17231000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 6729000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 962000.00
ASCU.TO income_statement (annual, 2021-12-31) — Other Special Charges: 613000.00
ASCU.TO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 118000.00
ASCU.TO income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -8400000.00
ASCU.TO income_statement (annual, 2022-12-31) — +Operating Expense: 6963000.00
ASCU.TO income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 995000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 70000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -94000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 7053000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 164000.00
ASCU.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 82276370.00
ASCU.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.09
ASCU.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 27307000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 110000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -29799000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -133000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 115000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 86016000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 19862000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 19862000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 19862000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 26088000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -29799000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -3554000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 515000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 28000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Change In Receivables: 166000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 709000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -7265000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Common Stock: 86016000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 65982000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 25926000.00
ASCU.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 84000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2474000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Current Assets: 20022000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 48000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 48000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 3529000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 83000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
ASCU.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 82276370.00
ASCU.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.09
ASCU.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — EBIT: -6746000.00
ASCU.TO income_statement (annual, 2022-12-31) — EBITDA: -6663000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -180000.00
ASCU.TO cash_flow (annual, 2022-12-31) — End Cash Position: 19862000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 26088000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -33353000.00
ASCU.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -60000.00
ASCU.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 5865000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2467000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 47019000.00
ASCU.TO income_statement (annual, 2022-12-31) — Gross Profit: -84000.00
ASCU.TO income_statement (annual, 2022-12-31) — Interest Expense: 375000.00
ASCU.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 375000.00
ASCU.TO income_statement (annual, 2022-12-31) — Interest Income: 316000.00
ASCU.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 316000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Interest Paid Cff: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 65982000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -29799000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 164000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 164000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 25926000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 2467000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 67000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 67000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
ASCU.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -48000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 313000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 25926000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 180000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Income: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -7121000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -7121000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Interest Income: -59000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -48000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -48000.00
ASCU.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -59000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -29025000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Net PPE: 46925000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -29666000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 63515000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
ASCU.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -6642000.00
ASCU.TO income_statement (annual, 2022-12-31) — Normalized Income: -7100000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3554000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 232000.00
ASCU.TO income_statement (annual, 2022-12-31) — Operating Income: -7047000.00
ASCU.TO income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 88832714.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 90000.00
ASCU.TO income_statement (annual, 2022-12-31) — Other Gand A: 712000.00
ASCU.TO income_statement (annual, 2022-12-31) — Other Income Expense: -15000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 2467000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 722000.00
ASCU.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 6000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Other Payable: 12000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Other Properties: 46596000.00
ASCU.TO income_statement (annual, 2022-12-31) — Other Special Charges: -39000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Payables: 1007000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3481000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 90000.00
ASCU.TO income_statement (annual, 2022-12-31) — Pretax Income: -7121000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 210000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -29666000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Receivables: 70000.00
ASCU.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 84000.00
ASCU.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 83000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -48000.00
ASCU.TO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -27087000.00
ASCU.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 5153000.00
ASCU.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1098000.00
ASCU.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 6963000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Share Issued: 88832714.00
ASCU.TO income_statement (annual, 2022-12-31) — Special Income Charges: 39000.00
ASCU.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1821000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 65982000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 63515000.00
ASCU.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Assets: 69578000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 65982000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Debt: 115000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 65982000.00
ASCU.TO income_statement (annual, 2022-12-31) — Total Expenses: 7047000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3596000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 49556000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 67000.00
ASCU.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -6963000.00
ASCU.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -21000.00
ASCU.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -21000.00
ASCU.TO balance_sheet (annual, 2022-12-31) — Working Capital: 16493000.00
ASCU.TO income_statement (annual, 2023-12-31) — +Operating Expense: 6341000.00
ASCU.TO income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 1189000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 10071000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -157000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 7456000.00
ASCU.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 105487376.00
ASCU.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.07
ASCU.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19862000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 63000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -27295000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -9000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 67000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 111167000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 10494000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 10494000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 10494000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 29533000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -27295000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -11524000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -5796000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -67000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 163000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -5700000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -9286000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Common Stock: 111167000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 84547000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 22776000.00
ASCU.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 63000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7012000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Current Assets: 20722000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 64000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 64000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 8386000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Depreciation: 110000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 111000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 110000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 10000000.00
ASCU.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 105487376.00
ASCU.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.07
ASCU.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — EBIT: -6497000.00
ASCU.TO income_statement (annual, 2023-12-31) — EBITDA: -6386000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -82000.00
ASCU.TO cash_flow (annual, 2023-12-31) — End Cash Position: 10494000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 29533000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -38819000.00
ASCU.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -11000.00
ASCU.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 5382000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3379000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 90136000.00
ASCU.TO income_statement (annual, 2023-12-31) — Gross Profit: -63000.00
ASCU.TO income_statement (annual, 2023-12-31) — Interest Expense: 492000.00
ASCU.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 492000.00
ASCU.TO income_statement (annual, 2023-12-31) — Interest Income: 859000.00
ASCU.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 859000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 84547000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -27295000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 0.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
ASCU.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 22776000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -64000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 322000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 22776000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 82000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Income: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -6989000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -6989000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Interest Income: 419000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -64000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -64000.00
ASCU.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 419000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 4853000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Net PPE: 89979000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -27286000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 81168000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 620000.00
ASCU.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -4016000.00
ASCU.TO income_statement (annual, 2023-12-31) — Normalized Income: -4619000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -11524000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -761000.00
ASCU.TO income_statement (annual, 2023-12-31) — Operating Income: -6404000.00
ASCU.TO income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 109067336.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 157000.00
ASCU.TO income_statement (annual, 2023-12-31) — Other Gand A: 566000.00
ASCU.TO income_statement (annual, 2023-12-31) — Other Income Expense: -1004000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3379000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -486000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 10524000.00
ASCU.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1366000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Other Payable: 121000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Other Properties: 89814000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Payables: 1310000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 8322000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -843000.00
ASCU.TO income_statement (annual, 2023-12-31) — Pretax Income: -6989000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1968000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -27286000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Receivables: 10071000.00
ASCU.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 63000.00
ASCU.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 111000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -64000.00
ASCU.TO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 2359000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -34076000.00
ASCU.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 4816000.00
ASCU.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 959000.00
ASCU.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 6341000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Share Issued: 109067336.00
ASCU.TO income_statement (annual, 2023-12-31) — Special Income Charges: -2359000.00
ASCU.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2301000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 84547000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 81168000.00
ASCU.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Assets: 114080000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 84547000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Debt: 67000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 84547000.00
ASCU.TO income_statement (annual, 2023-12-31) — Total Expenses: 6404000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 29533000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 93358000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 21147000.00
ASCU.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -6341000.00
ASCU.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: -52000.00
ASCU.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -2370000.00
ASCU.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2370000.00
ASCU.TO balance_sheet (annual, 2023-12-31) — Working Capital: 12336000.00
ASCU.TO balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -211000.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 109516209.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.02
ASCU.TO cash_flow (quarterly, 2024-09-30) — Capital Expenditure Reported: 0.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 109516209.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.02
ASCU.TO balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 4173000.00
ASCU.TO balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
ASCU.TO balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 322000.00
ASCU.TO cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 2798000.00
ASCU.TO balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 4173000.00
ASCU.TO cash_flow (quarterly, 2024-09-30) — Pension And Employee Benefit Expense: 0.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -27000.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
ASCU.TO income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
ASCU.TO income_statement (annual, 2024-12-31) — +Operating Expense: 5401000.00
ASCU.TO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 467000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 123000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -228000.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -228000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 8701000.00
ASCU.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 115092409.00
ASCU.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.06
ASCU.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10494000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -21882000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: 0.00
ASCU.TO cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: 0.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 16000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 137424000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 31741000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 31741000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 31741000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 54032000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -21882000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -9719000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: -5732000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Change In Payable: -5732000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -5732000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -13000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -52000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -5797000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 22431000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Common Stock: 137424000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 104609000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 25982000.00
ASCU.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 66000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2018000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Current Assets: 32034000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 16000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 16000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 8587000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 118000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 10000000.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 10000000.00
ASCU.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 115092409.00
ASCU.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.06
ASCU.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — EBIT: -6178000.00
ASCU.TO income_statement (annual, 2024-12-31) — EBITDA: -6060000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1184000.00
ASCU.TO cash_flow (annual, 2024-12-31) — End Cash Position: 31741000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 54032000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -31601000.00
ASCU.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 4175000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 4173000.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 4173000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 99486000.00
ASCU.TO income_statement (annual, 2024-12-31) — Gross Profit: -66000.00
ASCU.TO income_statement (annual, 2024-12-31) — Interest Expense: 1262000.00
ASCU.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1262000.00
ASCU.TO income_statement (annual, 2024-12-31) — Interest Income: 600000.00
ASCU.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 600000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 104609000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -21882000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 25982000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
ASCU.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -64000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 322000.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 322000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 25982000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 1184000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Income: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -7440000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -7440000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Interest Income: -2249000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -64000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -64000.00
ASCU.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2249000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 28000000.00
ASCU.TO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 5601000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Net PPE: 99258000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -21882000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 100436000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 785000.00
ASCU.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -6156000.00
ASCU.TO income_statement (annual, 2024-12-31) — Normalized Income: -7536000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -9719000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1184000.00
ASCU.TO income_statement (annual, 2024-12-31) — Operating Income: -5467000.00
ASCU.TO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 135523952.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 170000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 5980000.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 5980000.00
ASCU.TO income_statement (annual, 2024-12-31) — Other Gand A: 613000.00
ASCU.TO income_statement (annual, 2024-12-31) — Other Income Expense: 276000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 4173000.00
ASCU.TO balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 4173000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 809000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 11484000.00
ASCU.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 180000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Other Payable: 106000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Other Properties: 99164000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Payables: 573000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2591000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 0.00
ASCU.TO cash_flow (quarterly, 2024-12-31) — Pension And Employee Benefit Expense: 0.00
ASCU.TO income_statement (annual, 2024-12-31) — Pretax Income: -7440000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 114000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -21882000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Receivables: 123000.00
ASCU.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 66000.00
ASCU.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 118000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -64000.00
ASCU.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -96000.00
ASCU.TO income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: -96000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -41516000.00
ASCU.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 3562000.00
ASCU.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1226000.00
ASCU.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 5401000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Share Issued: 135523952.00
ASCU.TO income_statement (annual, 2024-12-31) — Special Income Charges: 96000.00
ASCU.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 96000.00
ASCU.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1407000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 104609000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 100436000.00
ASCU.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Assets: 135465000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 104609000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Debt: 16000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 104609000.00
ASCU.TO income_statement (annual, 2024-12-31) — Total Expenses: 5467000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 30856000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 103431000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 22269000.00
ASCU.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -5401000.00
ASCU.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 1587000.00
ASCU.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 96000.00
ASCU.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 96000.00
ASCU.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 96000.00
ASCU.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 96000.00
ASCU.TO balance_sheet (annual, 2024-12-31) — Working Capital: 23447000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 1479000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 845000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 147000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 9554000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 143970888.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
ASCU.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 31741000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -15270000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: 0.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 47000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 152409000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 31440000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 31440000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 31440000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 14969000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -15270000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1337000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 519000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -456000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 63000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1638000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 152409000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 118858000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 14985000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2201000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 32213000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 47000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 47000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3181000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 10000000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 143970888.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
ASCU.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — EBIT: -1478000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — EBITDA: -1473000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1337000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 31440000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 14969000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -16607000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1030000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 112746000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 0.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 111000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 111000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Interest Income: 292000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 292000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 118858000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -15270000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 14985000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -16000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 14985000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -1337000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Income: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1589000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1589000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 342000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -16000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -16000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 342000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 112746000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -15270000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 118858000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1375000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1473000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -1589000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1337000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1337000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Operating Income: -1479000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 148516758.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 626000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 26000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -452000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 667000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 11545000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -452000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 88000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 112746000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Payables: 933000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3134000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -1589000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -15270000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 147000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5000.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -16000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -43105000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1004000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 449000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1479000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 148516758.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
ASCU.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 854000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 118858000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 118858000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 144959000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 118858000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 47000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 118858000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 1479000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 26101000.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 112746000.00